Product Information
ONDANSETRON HCL 8 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.0781 per EA under NDC 55111015430. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 26, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111015430
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ONDANSETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076183FDA Approved
12/26/2006
TE Code
AB
On Market Since
12/26/2006
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON HCL 8 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 48.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0781 per EA |
|---|---|
| All-time high | $0.4333 (Jul 16, 2014) |
| All-time low | $0.0715 (Nov 20, 2024) |
| 52-week high | $0.0981 |
| 52-week low | $0.0781 |
| Median price | $0.1054 |
| Average price | $0.1629 |
| Largest weekly change | +111.5% (Jan 22, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ONDANSETRON HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ONDANSETRON HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON HCL 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON HCL 8 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.0781 per EA (NDC 55111015430), effective Sep 30, 2026.
How has the price of ONDANSETRON HCL 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONDANSETRON HCL 8 MG TABLET has declined 48.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ONDANSETRON HCL 8 MG TABLET?
Since Nov 28, 2013, the NADAC for ONDANSETRON HCL 8 MG TABLET has ranged from a low of $0.0715 (Nov 20, 2024) to a high of $0.4333 (Jul 16, 2014), with a median of $0.1054 per EA.
Are there cheaper alternatives to ONDANSETRON HCL 8 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ONDANSETRON HCL 8 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ONDANSETRON HCL 8 MG TABLET?
ONDANSETRON HCL 8 MG TABLET (NDC 55111015430) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.